Shares of therapeutic drug development company Prana Biotechnology (NASDAQ:PRAN) are tumbling after its clinical study of a drug being tested as a treatment of Alzheimer’s disease did not hit its primary endpoint. WHAT’S NEW: Prana released the top line results of the 12-month Phase II Imaging trial in Alzheimer’s disease “IMAGINE” Trial, based on draft results. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares after opening at $3.01 moved to $3.24 on last trade day and at the end of the day closed at $2.80. Company price to sales ratio in past twelve months was calculated as 391.53 and price to cash ratio as 6.71. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) showed a negative weekly performance of -74.96%.
Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014, deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (NASDAQ:GALE). Investors who bought Galena securities between Nov. 6, 2013, and Feb. 14, 2014 (the “Class Period”). Galena Biopharma Inc. (NASDAQ:GALE) shares advanced 12.61% in last trading session and ended the day on $2.50. GALE return on equity ratio is recorded as -435.40% and its return on assets is -113.60%. Galena Biopharma Inc. (NASDAQ:GALE) yearly performance is 20.77%.
Arotech Corporation (NASDAQ:ARTX) is slipping in extended trading after missing analysts’ estimates in its recent quarter. Arotech Corporation (NASDAQ:ARTX) shares moved up 6.87% in last trading session and was closed at $6.22, while trading in range of $6.02 – $6.61. Arotech Corporation (NASDAQ:ARTX) year to date (YTD) performance is 78.22%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) reported in the previous week, that it had initiated phase 1 testing of its drug candidate RX3117 which has been designed to treat cancer. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) weekly performance is -16.28%. On last trading day company shares ended up $1.08. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) distance from 50-day simple moving average (SMA50) is -6.57%. Analysts mean target price for the company is $2.50.